Just as bacteria can develop antibiotic resistance, viruses can also evade drug treatments. Developing therapies against these microbes is difficult because viruses often mutate or hide themselves within cells. But by mimicking ...
Aug 2, 2023
0
1
CAR-T immune therapies could be effective against solid tumors if the right targets are identified, a new study led by University of Illinois Urbana-Champaign researchers suggests. The researchers have successfully deployed ...
Aug 1, 2023
0
83
Immune checkpoint inhibitor (ICI) therapies used to treat cancer come with the risk of adverse autoimmune responses, including arthritis that can persist for years and require joint replacement surgery. Little is known about ...
Aug 1, 2023
0
74
New Alzheimer's research from UVA Health suggests that enhanced light sensitivity may contribute to "sundowning"—the worsening of the disease's symptoms late in the day—and spur sleep disruptions thought to contribute ...
Jul 27, 2023
0
22
In a promising form of immunotherapy known as CAR T-cell (chimeric antigen receptor) therapy, the patient's T cells are engineered to better recognize and attack antigens on the surface of cancer cells. In treatments currently ...
Jul 27, 2023
0
0
Scientists from Cardiff University have discovered a superior form of killer T-cell in patients who have successfully cleared end-stage solid cancer.
Jul 24, 2023
0
86
Extracellular vesicles, responsible for cell-to-cell communication, might be a driver of fibrosis in systemic sclerosis, according to a recent paper in Arthritis and Rheumatology.
Jul 21, 2023
0
25
University of Maryland School of Medicine (UMSOM) researchers engineered a new type of CAR T-cell therapy that, in preclinical studies, selectively attacked cancer cells while sparing healthy cells, potentially reducing the ...
Jul 20, 2023
0
46
Cell therapy holds promise as a new treatment for Parkinson's disease but, in many trials to date, most transplanted dopamine cells have failed to survive, raising a fundamental obstacle. Recent advancements led by researchers ...
Jul 13, 2023
0
59
A local study led by the Agency for Science, Technology and Research (A*STAR) discovered that by inhibiting the function of two proteins, G9a and GLP, during the cell therapy production process, immune cells could become ...
Jul 10, 2023
0
59
